Suppr超能文献

皮质醇、脱氢表雄酮和脱氢表雄酮硫酸盐在强迫症患者暴露治疗中的变化模式及其对治疗反应的预测。

Cortisol, DHEA and DHEA-S during exposure therapy in patients with obsessive-compulsive disorder - secretion patterns and prediction of treatment response.

机构信息

University Hospital Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Hamburg, Germany; Herford Hospital, Department of Psychiatry, Psychotherapy & Psychosomatics, Herford, Germany.

Max Planck Institute of Psychiatry, Department of Statistics and Biomathematics, Munich, Germany.

出版信息

Psychiatry Res. 2020 Sep;291:113288. doi: 10.1016/j.psychres.2020.113288. Epub 2020 Jul 10.

Abstract

The cortisol response in patients with obsessive-compulsive disorder (OCD) during exposure with response prevention (ERP), a stressful but very effective psychotherapeutic treatment, has shown contradictory findings in three prior studies with low sample sizes. In a larger cohort of 51 patients with OCD we repeatedly measured subjective units of distress (SUD) and the adrenocortical stress hormones cortisol, dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S) in saliva during the very first session of ERP and on the day before. Expectedly, SUD were increased on the ERP day before the session and further rose during ERP, but salivary cortisol and DHEA were statistically indistinguishable from the comparison condition. Interestingly, DHEA-S was significantly elevated throughout the ERP versus the comparison day, but did not further increase in acute response to ERP. According to an explorative analysis in a subsample, hormone levels on the comparison or the ERP day did not predict anti-OCD treatment response one month later. These results corroborate our prior findings of cortisol non-response despite considerable subjective stress in ERP. The role of DHEA-S in anticipatory anxiety and the effects of augmentative cortisol therapy in ERP need further study.

摘要

强迫症(OCD)患者在暴露反应预防(ERP)治疗期间,即一种压力很大但非常有效的心理治疗过程中,皮质醇的反应在三项先前的小样本研究中得出了相互矛盾的结果。在一项更大的 OCD 患者队列(51 名患者)中,我们在 ERP 的首次治疗过程中和前一天,反复测量了唾液中的主观痛苦单位(SUD)和应激激素皮质醇、脱氢表雄酮(DHEA)和硫酸脱氢表雄酮(DHEA-S)。正如预期的那样,SUD 在治疗前一天 ERP 治疗期间增加,并在 ERP 治疗期间进一步上升,但皮质醇和 DHEA 的唾液水平与对照组在统计学上没有区别。有趣的是,DHEA-S 在整个 ERP 治疗期间显著升高,而在 ERP 治疗的急性反应中没有进一步升高。根据亚组的一项探索性分析,在治疗前一天或 ERP 治疗当天的激素水平并不能预测一个月后 OCD 的治疗反应。这些结果证实了我们之前的发现,即在 ERP 治疗中,尽管有相当大的主观压力,但皮质醇并未产生反应。DHEA-S 在预期焦虑中的作用以及在 ERP 治疗中增强皮质醇治疗的效果需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验